在 COVID-19 期间的腹膜透析管理：中国四川省人民医院的经验。
Management of peritoneal dialysis under COVID-19: The experience in Sichuan Province People's Hospital, China.
机构信息
School of Medicine, 12599University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Renal Department and Institute of Nephrology, Sichuan Clinical Research Centre for Kidney Disease, 89669Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
出版信息
Perit Dial Int. 2021 Jan;41(1):42-48. doi: 10.1177/0896860820935298. Epub 2020 Jul 24.
The outbreak of coronavirus disease 2019 (COVID-19) is becoming a severe challenge to China and the whole world. By now, there is no report about medical support to peritoneal dialysis (PD) patient during COVID-19 pandemic. In this essay, we summed up our safety measures on how to protect PD patients and our staffs, and our experience on how to ensure the dialysis treatment of PD patients during the pandemic period. Using of telehealth has potential to improve patient care quality. As a result, by applying all the actions and efforts above, most of patients got enough medical support. According to the patient survey, 11 patients (3.3% of the total) reduced their treatment of dialysis exchange due to the shortage of PD solution or the affection of the pandemic. None of the PD patient and staff reported COVID-19. We successfully prevented COVID-19 transmission and ensured medical safety in our PD patients during the crisis.
2019 年冠状病毒病（COVID-19）的爆发对中国乃至全世界来说都是一个严峻的挑战。到目前为止，还没有关于 COVID-19 大流行期间腹膜透析（PD）患者医疗支持的报道。在本文中，我们总结了在大流行期间保护 PD 患者及其工作人员的安全措施，以及确保 PD 患者透析治疗的经验。远程医疗的应用具有提高患者护理质量的潜力。因此，通过实施上述所有措施和努力，大多数患者得到了足够的医疗支持。根据患者调查，由于 PD 液短缺或疫情影响，有 11 名患者（占总人数的 3.3%）减少了透析交换治疗。没有 PD 患者和工作人员报告 COVID-19 感染。我们成功地防止了 COVID-19 的传播，并确保了我们 PD 患者在危机期间的医疗安全。
Zotero 插件